Predominance of Candidatropicalis bloodstream infections in a Singapore teaching hospital

References

• Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317
   PubMed Web of Science ®Google Scholar
• Girmenia C, Martino P. Fluconazole and changing epidemiology of candidemia. Clin Infect Dis 2001; 27: 232–233
   Google Scholar
• Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance programme in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000; 44: 747–751
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for Candida bloodstream infections in surgical intensive care unit patient: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177–186
   PubMed Web of Science ®Google Scholar
• Marchetti, Bille J, Fluckier U, et al. Fungal infection network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends 1991–2000. Clin Infect Dis 2004; 38: 311–320
   PubMed Web of Science ®Google Scholar
• Matar MJ, Otrosky-Zeichner L, Paetznick VL, et al. Correlation between E-test, disk diffusion and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003; 47: 1647–1651
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standard Reference, 2002. Reference method for broth microdilution antifungal susceptibility of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
   Google Scholar
• Roilides E, Farmaki E, Evdoridou J, et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 2003; 41: 735–741
   PubMedGoogle Scholar
• Abi-Said D, Anaissie E, Uzum O, et al. The epidemiology of hematogenous candidiasis by different Candida species. Clin Infect Dis 1997; 24: 1122–1128
   PubMed Web of Science ®Google Scholar
• Oon LL, Yeo MG. Fluconazole susceptibility of Candida species in Singapore by disc diffusion test. Ann Acad Med Singapore 2003; 31: 497–501
   Google Scholar
• Foongladda S, Sakulmaiwatana P, Petlum P, Vamprapar N. Candida species, genotype and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999–2002. J Med Assoc Thai 87; 2004: 92–99
   Google Scholar
• Matthews MS, Samuel P, Suresh M. Emergence of Candida tropicalis as the major cause of fungaemia in India. Mycoses 2001; 44: 278–280
   Google Scholar
• Al-Jasser AM, Elkhizzi NA. Distribution of Candida species among bloodstream isolates. Saudi Med J 2004; 25: 566–569
   PubMed Web of Science ®Google Scholar
• Weinberger M, Leibovici L, Perez S, Samra Z, et al. Characteristics of candidemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 2005; 61: 146–154
   PubMedGoogle Scholar
• Chen YC, Chang SC, Luh KT, Hsieh WC. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during past 10 years. J Antimicrob Chemother 2003; 52: 71–77
   PubMed Web of Science ®Google Scholar
• Takakura S, Fujihara N, Saito T, et al. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six anti-fungal agents including voriconazole and micafungin. J Antimicrob Chemother 2004; 53: 283–289
   PubMed Web of Science ®Google Scholar
• Yang, YL, Ho, YA, Cheng, HH, Lo, HJ, TSARY Hospitals. Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. Epidemiol Infect 2005; 133: 325–330.
   Google Scholar
• Berrouane YF, Herwaldt LA, Pfaller MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 1999; 37: 531–537
   PubMed Web of Science ®Google Scholar
• Myoken Y, Kyo T, Kohara T, et al. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica 2004; 89: 378–380
   Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163
   PubMed Web of Science ®Google Scholar